To hear about similar clinical trials, please enter your email below
Trial Title:
Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022
NCT ID:
NCT05595252
Condition:
Cervical Intraepithelial Neoplasia
Conditions: Official terms:
Uterine Cervical Dysplasia
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Biological
Intervention name:
cervical biopsy
Description:
cervical biopsy made during and after pregancy
Arm group label:
Patients with CIN lésions during pregnancy
Summary:
In France, the screening rate for cervical cancer remains too low. Screening is simple
and non-invasive.
Pregnant patients are most of the time young and are part of the target population for
screening, and for many women, it is the first encounter with a gynecologist.
The cervical smear is therefore an important step of the first consultation during
pregnancy In the case of pathological results, colposcopies with biopsies are performed,
frequently finding CIN 1 to 3. (cervical intraepithelial neoplasia) These CIN lesions
evolve slowly and most of the time, treatment can be withheld until the end of the
pregnancy.
Several studies suggest a higher regression rate in pregnant patients. Our study will
evaluate the rate of regression, progression or persistence of these lesions in per and
post partum patients in Nancy, between 2014 and 2022.
To obtain our results, we will compare the results of per and post partum biopsies in
each patient.
In a second step, we will study the risk factors of aggravation or on the contrary the
protective factors, allowing a faster regression of the lesions
Criteria for eligibility:
Study pop:
study on patients who were pregnant and have a CIN lesion at the same time, care at the
MRUN, the Nancy Régional Maternity between 2014 and 2022
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- women who have a CIN lesion during pregnancy
- in Nancy, France, MRUN Center
- between 2014 and 2022
Exclusion Criteria:
- lost of follow up women
Gender:
Female
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
BENOIT Camille
Address:
City:
Nancy
Zip:
54000
Country:
France
Start date:
January 1, 2014
Completion date:
December 31, 2022
Lead sponsor:
Agency:
Central Hospital, Nancy, France
Agency class:
Other
Source:
Central Hospital, Nancy, France
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05595252
